VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Recruiting
N/A
Interventional Study
Atrophic Vaginitis
Vaginal Atrophy
Genitourinary Syndrome of Menopause
Lichen Sclerosus of Vulva
Lichen Planus of Vulva
Lichen Simplex of Vulva (Disorder)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 2,000 (estimated)
- Sponsor
- Stratpharma AG · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichen planus
* Continuous vulvovaginal symptoms
* Access to smartphone and tablet, laptop or computer
* Access to a valid email address
Exclusion Criteria:
* Unable to provide informed consent
* Pat…
Contacts
No contact information available.